Thromb Haemost 1965; 13(02): 394-400
DOI: 10.1055/s-0038-1656239
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH Schattauer

Factors Effecting the Electrophoretic Mobility of Prothrombin

Andrew C. Peacock
1   Diagnostic Research Branch, National Cancer Institute, National Institutes of Health, Bethesda 14, Maryland
,
Roswell A. Reed
1   Diagnostic Research Branch, National Cancer Institute, National Institutes of Health, Bethesda 14, Maryland
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Summary

Semipurified preparations of prothrombin were found to migrate slightly faster than albumin when studied by continuous flow electrophoresis. In contrast, similar studies with plasma, and serum enriched with prothrombin showed substantially slower migration rates for prothrombin. Albumin was shown to be one of the plasma constituents responsible for this change in prothrombin mobility. The broad range of prothrombin mobilities found in plasma is ascribed to multiple interactions between prothrombin and the plasma proteins, and not to the existence of isozymes of prothrombin.

 
  • References

  • 1 Tishkoff G. H, Pechet L, Alexander B. Some Biochemical and Electrophoretic Studies on Purified Prothrombin, Factor VII (Proconvertin) and Factor X (Stuart). Blood 15: 778 1960;
  • 2 Pechet L, Alexander B, Tishkojf G. H. Separation, Interaction and Properties of Clotting Components Essential for Prothrombin Activation with Special Reference to Stuart Factor. Thrombos. Diathes. haemorrh. (Stuttg.). 4. Supp. 47 1960
  • 3 Lanchantin G. F. An Analysis of Human Prothrombin by Starch Block Electrophoresis. Amer. J. Physiol. 194: 7 1958;
  • 4 Lewis J. H, Walters D, Didisheim P. Application of Continuous Flow Electrophoresis to the Study of Blood Coagulation Proteins and the Fibrinolytic System. I. Normal Human Materials. J. clin. Invest 37: 1323 1958;
  • 5 Johnston Jr. G. L, Ferguson J. H, O’Hanion F. A, Payne R. B. Isolation of Coagulation Factors by Continuous Flow Electrophoresis. Proc. Soc. exp. Biol. (N. Y.) 101: 747 1959;
  • 6 Perry S. Coagulation Factors in Patients with Plasma Protein Disorders. J. Lab. clin. Med. 61: 411 1963;
  • 7 Allen R. C, Meiser H, Hoag W. G. Distribution of Coagulation Proteins in Normal Mouse Plasma. Science 135: 103 1962;
  • 8 Raymond S, Nakamichi M, Aureli B. Acrylamide gel as an Electrophoresis Medium. Nature 198: 696 1962;
  • 9 Ware A. G, Seegers W. H. Quantitative Two-Stage Procedure for the Determination of Prothrombin Concentration. Amer. J. clin. Path. 19: 471 1949;
  • 10 Peacock A. C. Formation of Thromboplastic Activity with Russell’s Viper Venom. J. Lab. clin. Med. 57: 703 1961;
  • 11 Owen Jr. G. A, McKenzie B. F. Application of Paper Electrophoresis to Separation of Blood Clotting Factors. J. appi. Physiol. 6: 696 1954;
  • 12 Strain H. H, Sullivan J. C. Analysis by Electromigration plus Chromatography. Anal. Chem. 23: 816 1951;
  • 13 Pucar Z. Kontinuierliche Electrophorese und Zweidimensional Electrochromatographie. J. Chromatog. 4: 261 1960;